The Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Institute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
The Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Thromb Res. 2021 Jun;202:8-13. doi: 10.1016/j.thromres.2021.02.027. Epub 2021 Mar 3.
The reported variants of hemophilia A are mainly from European subjects and American subjects of European descent, and limited data are available from more diverse ethnic backgrounds. This study was performed to identify the causative variants in a large HA cohort from Chinese population.
A total of 236 HA pedigrees were included. Molecular analysis of F8 gene was performed using next-generation sequencing (NGS) and then validated by Sanger sequencing and multiplex ligation probe amplification (MLPA) results. Variants were classified as pathogenic, likely pathogenic, variant of unknown significance, likely benign, and benign according to the American College of Medical Genetics and Genomics guidelines.
A total of 186 F8 variants were identified, with 139 (139/186, 74.73%) point mutations, 44 (44/186, 23.66%) small insertions/deletions (InDels), and 3 (3/186, 1.61%) large deletions, they included 80 pathogenic and 84 likely pathogenic variants. Of these variants, 119 had been reported previously, and 67 were novel. No potentially causative mutations were found in the targeted F8 region in seventeen HA pedigrees.
The spectrum of F8 variants identified in this study provides additional information about HA and enriches our knowledge of the variant spectrum in a wider range of ethnic backgrounds.
已报道的血友病 A 变异主要来自欧洲和欧洲裔美国人群,来自更多样化种族背景的数据有限。本研究旨在鉴定来自中国人群的大型血友病 A 队列中的致病变异。
共纳入 236 个血友病 A 家系。使用下一代测序(NGS)对 F8 基因进行分子分析,然后通过 Sanger 测序和多重连接探针扩增(MLPA)结果进行验证。根据美国医学遗传学与基因组学学院的指南,将变异分为致病性、可能致病性、意义不明的变异、可能良性和良性。
共鉴定出 186 个 F8 变异,其中 139 个(139/186,74.73%)为点突变,44 个(44/186,23.66%)为小插入/缺失(InDels),3 个(3/186,1.61%)为大片段缺失,包括 80 个致病性和 84 个可能致病性变异。这些变异中有 119 个先前已有报道,67 个为新变异。在 17 个血友病 A 家系中未发现目标 F8 区域的潜在致病突变。
本研究鉴定的 F8 变异谱提供了关于血友病 A 的更多信息,并丰富了我们对更广泛种族背景下变异谱的认识。